Measuring liver fat with light during transplant or surgery
Part of Digestive system clinical trials.
This study uses a special light-based device (near-infrared spectroscopy) to measure fat in the liver without needing extra invasive tests. It may help doctors better assess liver health before transplant or surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- For liver donors: You are 18 or older and are accepted as a donor (including after cardiac death, even if the liver is on a machine).
- For patients: You are 18 or older and are having surgery to remove part or all of your liver (hepatectomy).
- You are covered by French health insurance (patients).
- You have received information about the study and agreed to participate (or, for donors, your family does not object).
- You are not in an excluded group (e.g., pregnant, under guardianship, or unable to understand French for patients).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new way to monitor blood flow in tiny blood vessels during liver transplant surgery. It may help doctors better understand how well blood is reaching tissues during the operation.
This study looks at stored medical data from living liver donors to better understand fat in the liver (steatosis). It may help improve future transplant care.
This study uses a tiny probe placed in the new liver during transplant surgery to monitor its health in real time. It may help doctors detect problems early and improve recovery after transplant.
This study uses advanced techniques to analyze liver tissue samples from people with various liver conditions. It aims to better understand how liver diseases develop and progress, which may help improve future treatments.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study is looking for new ways to detect liver scarring (fibrosis) in people with fatty liver disease (NAFLD, NASH, MASLD, or MASH). If you qualify, you will give a blood sample to help identify biomarkers that could replace biopsies.
Hear when a new Hepatic Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.